advertisement
Abstract #92720 Published in IGR 22-1
Netarsudil-related Eyelid Wound Dehiscence
Kim HM; Tran AQ; Yang C; Dagi Glass LRJournal of Glaucoma 2021; 30: 206-208
An 81-year-old man with primary open-angle glaucoma on dorzolamide-timolol, bimatoprost and 0.02% netarsudil ophthalmic solution (Rhopressa), was found to have right lower lid basal cell carcinoma. The patient underwent Mohs surgery followed by repair of the right lower lid, with 3 episodes of wound dehiscence. When stopping netarsudil, appropriate granulation tissue was able to develop. While off netarsudil, the patient underwent Mohs resection of a left lower lid basal cell carcinoma, which was able to granulate well via secondary intention.
Department of Ophthalmology, Columbia University Vagelos College of Physicians and Surgeons.
Full articleClassification:
11.14 Investigational drugs; pharmacological experiments (Part of: 11 Medical treatment)
